Venturi Wealth Management LLC Sells 3,066 Shares of Lam Research Corporation $LRCX

Venturi Wealth Management LLC trimmed its position in Lam Research Corporation (NASDAQ:LRCX) by 18.2% in the 3rd quarter, Holdings Channel.com reports. The institutional investor owned 13,804 shares of the semiconductor company’s stock after selling 3,066 shares during the quarter. Venturi Wealth Management LLC’s holdings in Lam Research were worth $1,848,000 as of its most recent SEC filing.

A number of other hedge funds also recently added to or reduced their stakes in LRCX. IMG Wealth Management Inc. bought a new stake in shares of Lam Research in the 2nd quarter valued at about $26,000. Howard Hughes Medical Institute bought a new position in Lam Research in the second quarter worth approximately $27,000. Strategic Wealth Investment Group LLC purchased a new stake in Lam Research during the second quarter worth $29,000. Delos Wealth Advisors LLC purchased a new stake in Lam Research during the second quarter worth $30,000. Finally, REAP Financial Group LLC bought a new stake in Lam Research during the 2nd quarter valued at $31,000. 84.61% of the stock is owned by hedge funds and other institutional investors.

Lam Research Trading Down 1.8%

Shares of NASDAQ:LRCX opened at $203.18 on Thursday. The company has a quick ratio of 1.60, a current ratio of 2.21 and a debt-to-equity ratio of 0.37. Lam Research Corporation has a 52-week low of $56.32 and a 52-week high of $210.45. The stock has a market cap of $255.19 billion, a price-to-earnings ratio of 44.75, a PEG ratio of 2.39 and a beta of 1.77. The business has a 50-day moving average price of $163.98 and a 200-day moving average price of $131.44.

Lam Research (NASDAQ:LRCX) last issued its quarterly earnings results on Wednesday, October 22nd. The semiconductor company reported $1.26 earnings per share for the quarter, topping the consensus estimate of $1.22 by $0.04. Lam Research had a net margin of 29.66% and a return on equity of 60.60%. The company had revenue of $5.32 billion for the quarter, compared to the consensus estimate of $5.23 billion. During the same quarter in the prior year, the company earned $0.86 EPS. Lam Research’s quarterly revenue was up 27.7% on a year-over-year basis. Lam Research has set its Q2 2026 guidance at 1.050-1.250 EPS. Equities analysts predict that Lam Research Corporation will post 3.71 EPS for the current year.

Lam Research Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Wednesday, January 7th. Investors of record on Wednesday, December 3rd were issued a dividend of $0.26 per share. This represents a $1.04 annualized dividend and a dividend yield of 0.5%. The ex-dividend date of this dividend was Wednesday, December 3rd. Lam Research’s dividend payout ratio (DPR) is 22.91%.

Analyst Ratings Changes

A number of equities research analysts recently weighed in on the company. Citigroup upped their price objective on Lam Research from $175.00 to $190.00 and gave the stock a “buy” rating in a research note on Tuesday, November 11th. UBS Group reissued a “buy” rating and set a $200.00 price target (up from $175.00) on shares of Lam Research in a research report on Tuesday, December 23rd. Cantor Fitzgerald restated an “overweight” rating and issued a $265.00 price target on shares of Lam Research in a report on Thursday. Mizuho lifted their price target on shares of Lam Research from $170.00 to $200.00 and gave the stock an “outperform” rating in a report on Wednesday, December 17th. Finally, HSBC set a $127.00 price objective on Lam Research and gave the stock a “hold” rating in a research report on Tuesday, September 30th. Twenty-six research analysts have rated the stock with a Buy rating and ten have issued a Hold rating to the company. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $163.04.

Insider Buying and Selling at Lam Research

In other Lam Research news, Director Bethany Mayer sold 1,298 shares of the company’s stock in a transaction on Monday, November 3rd. The shares were sold at an average price of $159.99, for a total value of $207,667.02. Following the sale, the director directly owned 1,652 shares of the company’s stock, valued at approximately $264,303.48. This represents a 44.00% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Ava Harter sold 9,010 shares of the stock in a transaction dated Monday, October 27th. The stock was sold at an average price of $157.47, for a total value of $1,418,804.70. Following the sale, the insider directly owned 56,786 shares in the company, valued at $8,942,091.42. This represents a 13.69% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last ninety days, insiders have sold 102,608 shares of company stock valued at $14,916,496. Company insiders own 0.31% of the company’s stock.

Lam Research Profile

Lam Research Corporation (NASDAQ: LRCX) is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.

Lam’s product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.